Viraleze shows antiviral efficacy in COVID-19 patients
Filed with ASX · · 5 pages · English
Starpharma Holdings Limited on 6ix
Earlier from Starpharma
- VivaGel BV sales and distribution agreement MENA region
- Positive DEP docetaxel Phase 2 results
- AGM Chairman's address and CEO presentation
- Starpharma announces new CEO, Ms Cheryl Maley
- Starpharma receives $7.2 million R&D Tax Incentive refund
Later from Starpharma
- VivaGel BV US FDA Appeal Outcome
- S&P DJI Announces March 2024 Quarterly Rebalance
- Starpharma and Medicxi Partnership Petalion Therapeutics
- Starpharma Business Update
- Positive final DEP irinotecan Phase 2 clinical trial results
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma